Orphan Drug 2022 Report 英語版
Treatments for orphan indications and rare diseases are no longer a niche area of focus for developers. Orphan products have become one of the fastest growing areas of…
Orphan Drug 2022 Report
Treatments for orphan indications and rare diseases are no longer a niche area of focus for developers. Orphan products have become one of the fastest growing areas of…
Orphan Drug 2022 Infographic 英語版
In 2021, over half of the FDA’s new drug approvals were for orphan or rare diseases. While orphan products are one of the fastest-growing areas of drug development, it…
Orphan Drug 2022 Infographic
In 2021, over half of the FDA’s new drug approvals were for orphan or rare diseases. While orphan products are one of the fastest-growing areas of drug development, it…
Evaluate Pharma®ワールドプレビュー2021 2026年への展望 インフォグラフィック
Evaluate Pharma®ワールドプレビュー2021 2026年への展望 製薬業界動向レポートの分析ハイライトを、インフォグラフィックでご覧いただけます。 製薬業界…
Evaluate Pharma®ワールドプレビュー2021 2026年への展望 レポート 日本語版
製薬業界動向レポート2021 Evaluate Pharma®ワールドプレビュー2021 2026年への展望…
Evaluate Pharma World Preview 2021, Outlook to 2026
We provide top-level insights and analyses on all the key trends in the fourteenth edition of the Evaluate Pharma World Preview 2021, Outlook to 2026 report. Our most…
Evaluate Pharma World Preview 2021, Outlook to 2026 Infographic（英語版）
This infographic showcases the key insights from the Evaluate Pharma World Preview, Outlook to 2026 report, at a time when the biopharma sector is under intense…
Evaluate Pharma World Preview 2021, Outlook to 2026 Infographic
This infographic showcases the key insights from the Evaluate Pharma World Preview, Outlook to 2026 report, at a time when the biopharma sector is under intense…
